Fasting insulin, HOMA-IR and HbA1c: which one shows problems first

Three markers of the same process, on very different timelines. Fasting insulin moves years before HbA1c does.

Key takeaways

  • Fasting insulin, HOMA-IR and HbA1c describe one process on three timelines. Insulin moves first, HbA1c last.
  • HOMA-IR combines fasting insulin and fasting glucose into a single index, which is why it is more informative than either alone.
  • HbA1c reflects average glucose over roughly the preceding three months and is affected by red cell lifespan, anemia and hemoglobin variants.
  • Standard reference ranges flag disease. They do not flag the decade of drift before it.
  • None of these are diagnostic on their own, and a diagnosis of diabetes or prediabetes belongs to a clinician using established criteria.

Insulin resistance develops for years while blood glucose stays normal, because rising insulin output is what keeps it normal.

Fasting insulin captures that compensation. HOMA-IR combines fasting insulin and glucose into one number. HbA1c reflects average glucose over roughly the previous three months, which makes it the last of the three to move.

A standard metabolic panel usually reports glucose and not insulin, which is why people are told everything is normal while the process is well underway.

Why insulin moves before glucose

Insulin resistance means tissues respond less to a given amount of insulin. The body's response is to produce more, and that extra output is effective for a long time. Glucose stays normal because insulin is working harder to keep it there.

So the sequence is: sensitivity falls, insulin rises, glucose stays normal, and eventually the pancreas cannot keep pace and glucose finally drifts up. A panel that measures only glucose is watching the last act. Longitudinal cohort work has documented this pattern, with metabolic changes detectable years before diagnosis.

The three markers, precisely

Each answers a different question, and the differences are the point.

  • Fasting insulin: how much insulin your pancreas is producing to hold the line. The earliest of the three to move.
  • HOMA-IR: fasting insulin in microunits per milliliter multiplied by fasting glucose in mg/dL, divided by 405. It puts the two together, so a normal glucose achieved with high insulin no longer looks normal.
  • HbA1c: the fraction of hemoglobin that is glycated, reflecting average glucose over roughly the previous three months. The slowest to move and the most familiar.

How the numbers are read

Diagnostic thresholds are set by the American Diabetes Association: HbA1c 5.7 to 6.4% indicates prediabetes, and 6.5% or above meets the criterion for diabetes on a confirmed test. Fasting glucose of 100 to 125 mg/dL indicates prediabetes, and 126 mg/dL or above meets the diabetes criterion.

Those are disease thresholds, and they do the job they were designed for. They are not descriptions of good metabolic function, because the ranges they sit inside were built from populations that include a great many people already drifting. Many longevity-oriented clinicians aim lower than the disease thresholds, for example fasting insulin in the low single digits, HOMA-IR near or below 1.0, HbA1c in the high 4s to low 5s, and fasting glucose in the 70s to mid 80s. Those are preferences drawn from the prevention literature rather than validated cutoffs.

Two honest caveats. HOMA-IR is a research index with real limitations, it varies between assays and it is less reliable at the extremes, so it is used as a trend rather than a verdict. And it is not a diagnostic test.

What can distort HbA1c

HbA1c depends on red blood cells living a normal length of time. Anything that changes that changes the result, independent of your actual glucose.

  • Iron deficiency anemia can raise HbA1c. Hemolytic anemia and recent blood loss can lower it.
  • Hemoglobin variants, including sickle cell trait and hemoglobin C, can interfere depending on the assay method.
  • Chronic kidney disease, pregnancy and recent transfusion all affect interpretation.
  • If your HbA1c and your fasting glucose consistently tell different stories, that discrepancy is itself worth investigating.

What actually moves them

Insulin sensitivity responds to a short list of inputs applied consistently, and the effect sizes are not small. Zone 2 cardio increases the muscle's capacity to clear glucose. Resistance training enlarges the tank that glucose is stored in. Protein and fiber early in a meal blunt the curve that follows. Sleep restriction measurably reduces next-day insulin sensitivity in controlled studies, and alcohol does its own damage.

Where lifestyle work does not close the gap, evaluation may support pharmacologic help, including GLP-1 therapy when a provider judges it appropriate. That is a clinical decision made with your full panel, not a conclusion to draw from a lab result and an article.

What this means for you

If you have been told your glucose is normal but something feels off, ask for fasting insulin and HOMA-IR. They are the two numbers most likely to explain the gap, and the two most often left off the panel.

Therapies discussed here

References

  1. American Diabetes Association, Standards of Care in Diabetes, classification and diagnosis
  2. Matthews et al., homeostasis model assessment, Diabetologia, 1985
  3. Tabák et al., trajectories of glycaemia and insulin sensitivity before diabetes diagnosis, Whitehall II, The Lancet, 2009
  4. Biomarker hub: Metabolic biomarkers
  5. Focus areas: Metabolic health

More in Biomarker hub